Extrait

Background and study aims Diabetes is a lifelong condition that causes a person's blood sugar level to become too high. About 415 million people suffered from diabetes in 2014 and it is expected that this will increase to 642 million by 2040. In Pakistan, about 6.9% of the adults suffered from diabetes in 2015 and it is estimated that this will increase up to 8.2% by 2040. Presently, in Pakistan, most people visit public and private sector hospitals for the management and treatment of diabetes, but since the doctors are extremely overburdened in most healthcare settings, they cannot give ample consultation time to the patients. In Pakistan, one doctor caters to the healthcare needs of almost 1073 patients, which represents a very low doctor to patient ratio. The problem can be dealt effectively if community pharmacists play a role in controlling and managing diabetes. Community pharmacists have ample medical knowledge and can provide both the appropriate information as well as sufficient time for controlling and managing diabetes. To date, very few studies from Pakistan have explored the role of pharmacists in diabetes management, specifically in community pharmacies. The aim of this study is to assess the impact of pharmacist-led interventions on blood sugar control and patient satisfaction in diabetes management at a community pharmacy. Who can participate? Patients aged 18-70 with type 2 diabetes What does the study involve? Participants are randomly allocated to either the control or the experimental group. The control group receive routine medications and diet plan. The experimental group receive interventions about self-management, quality of life, medication adherence, blood sugar control and knowledge about the disease. Information is provided through a diet chart, a foot care chart, and a low and high blood sugar chart, and the importance of exercise and medication by conversation with the participants. All participants are followed up 1 month later to check their blood sugar and their satisfaction with the services provided during this study. What are the possible benefits and risks of participating? The study may help the patient to control and manage their diabetes. There are no direct risks associated with participating in this study. Where is the study run from? Well Plus Community Pharmacy (Pakistan) When is the study starting and how long is it expected to run for? December 2016 to August 2017 Who is funding the study? Investigator initiated and funded (Pakistan) Who is the main contact? Mr Muhammad Abubakar

Critère d'inclusion

• Type 2 diabetes mellitus

Liens

• isrctn